Friday, June 26, 2009

Dr. Thomas Kollars, Chief Scientific Advisor for MIT and his New Biopesticide ProVectorTM Bti Designed to Eradicate Mosquitoes Featured on CNN

Dr. Thomas Kollars, Chief Scientific Advisor for MIT and his New Biopesticide ProVectorTM Bti Designed to Eradicate Mosquitoes Featured on a CNN inside Africa Report Concerning Malaria

(BUSINESS WIRE)--CNN recently aired a feature story on Dr. Kollars new invention the ProVectorTM Bti a flower containing the biopesticide Bacillus thuringiensis israelensis (Bti) for use in killing mosquitoes especially those transmitting deadly diseases such as malaria, dengue fever, rift valley fever, and others. (Copy and paste the following to your browser to see the CNN report)

What makes ProVectorTM Bti unique is, it is the first commercially available device to imitate a flower to which adult mosquitoes will come to feed on digesting the biopesticide Bti contained inside. It was designed with the philosophy of keeping “Green” and made of virtually indestructible plastic which reduces waste and it only allows mosquitoes to feed on it, eliminating the spread of pesticides into the environment. Dr. Kollars’ believes his invention will help to reduce mosquito populations down in geographical locations to threshold levels where in nature these types of diseases will cycle out of the mosquito population.

Forward-Looking Statements

Some of the information contained in this release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933 (the "Securities Act") and Section 21E of the Securities and Exchange Act of 1934 the "Exchange Act"), which mean that they relate to events or transactions that have not yet occurred, our expectations or estimates for our future operations, our growth strategies or business plans or other facts that have not yet occurred. These statements can be identified by the use of forward-looking terminology such as "might," "may," "could," "expect," "anticipate," "estimate," "likely," "intend," "believe," or "continue" or the negative thereof or other variations thereon or comparable terminology. For an explanation of some of the risks and uncertainties facing MIT HOLDING and its investors, please see our most recent prospectus on file with the Securities Exchange Commission. The risk factors contained therein should be considered by prospective investors for their potential impact on forward-looking statements included in this release. These important factors, among others that might not be listed, may cause actual results to differ materially and adversely from the results expressed or implied by the forward-looking statements. We caution investors that such discussions of important risks and uncertainties are not exclusive, and our business may be subject to other risks and uncertainties, which are not detailed there.

Investors are cautioned not to place undue reliance on our forward-looking statements. We make forward-looking statements as of the date of this release, and we assume no obligation to update the forward-looking statements after the date hereof whether as a result of new information or events, changed circumstances, or otherwise, except as required by law.

Fayette Front Page
Georgia Front Page

No comments: